Condensed Consolidated Statements of Operation (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Revenue		$ 950		$ 950
Cost of revenue		868		868
Gross profit		82		82
Operating expenses:
Research and development	128,660	194,155	259,501	388,162
General and administrative	305,560	306,213	585,292	614,054
Sales and marketing	73,780	101,214	148,634	180,627
Total operating expenses	508,000	601,582	993,427	1,182,843
Loss from operations	(508,000)	(601,500)	(993,427)	(1,182,761)
Other income (expense)
Interest expense	(266,496)	(208,347)	(815,230)	(579,299)
Change in fair value of derivative and warrant liabilities	(452,019)	624,873	(284,232)	(262,621)
Amortization of derivative and warrant liabilities discount	(137,618)	(94,735)	(268,026)	(236,296)
Amortization of deferred debt issuance costs and original issue discount	(7,978)	(62,920)	(14,712)	(125,450)
Gain on extinguishment of debt	161,573	245,908	172,124	247,074
Income (loss) on foreign exchange transactions	(32,436)	13,616	(38,529)	4,691
Other income (expense), net	(8,233)	(5,077)	(12,951)	(9,854)
Non operating Income (Expense), net	(743,207)	513,318	(1,261,556)	(961,755)
Net loss	$ (1,251,207)	$ (88,182)	$ (2,254,983)	$ (2,144,516)
Basic and diluted loss per share	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding: Basic and diluted	1,490,570,290	668,866,352	1,291,451,398	640,797,803